Ifosfamide
Ifex (ifosfamide) is a small molecule pharmaceutical. Ifosfamide was first approved as Ifex on 1988-12-30. It is used to treat b-cell chronic lymphocytic leukemia, breast neoplasms, hodgkin disease, lung neoplasms, and non-hodgkin lymphoma amongst others in the USA.
| Trade Name | Ifex |
|---|---|
| Common Name | Ifosfamide |
| Indication | b-cell chronic lymphocytic leukemia, breast neoplasms, hodgkin disease, lung neoplasms, non-hodgkin lymphoma, ovarian neoplasms, pancreatic neoplasms, precursor cell lymphoblastic leukemia-lymphoma, sarcoma, stomach neoplasms, testicular neoplasms |
| Drug Class | Phosphoro-derivatives; isophosphoramide mustard derivatives |
